Guardant Health, Inc. GH
177.25
0.80
0.45%
as of 25 Sep
- Market cap
- $23.9B
- P/E
- 0.0×
Follow GH
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 171.64% | 200.62% | 348.42% | 192.39% |
+8 more TTM periods Free account |
|
| (27.95%) | (26.58%) | (23.79%) | (28.33%) | ||
ROIC |
(129.70%) | (127.36%) | (134.56%) | (153.52%) | |
Return on Tangible Assets |
(38.40%) | (35.35%) | (31.80%) | (55.65%) | |
Average Days of Receivables |
44.50 | 46.43 | 51.24 | 46.74 | |
Free Cash Flow per Share |
(1.81) | (1.81) | (1.86) | (2.10) | |
Free Cash Flow |
(240.72) | (237.12) | (233.07) | (262.23) | |
Capital Expenditures |
(55.54) | (49.43) | (48.31) | (39.33) | |
Piotroski F-Score |
6.00 | 6.00 | 6.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
(7.94%) | (7.74%) | (7.09%) | (16.63%) | |
Accounts Receivable Turnover |
8.62 | 8.55 | 7.92 | 8.85 | |
Accounts Payable Turnover |
5.99 | 6.08 | 7.51 | 18.37 | |
Inventory Turnover |
4.37 | 4.71 | 4.45 | 4.02 | |
Average Days of Payables |
82.46 | 72.22 | 56.94 | 22.48 | |
Days of Inventory on Hand |
92.99 | 80.71 | 89.81 | 100.97 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
31.76% | 33.95% | 37.09% | 39.83% | |
Selling, General and Administrative Expense of Revenue |
73.00% | 72.38% | 71.90% | 72.95% | |
Share Based Compensation of Revenue |
16.17% | 16.30% | 16.93% | 17.66% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.41 | 0.43 | 0.44 | 0.56 | |
Depreciation/Fixed assets |
0.16 | 0.18 | 0.23 | 0.27 | |
Capex/Depreciation |
(2.19) | (1.84) | (1.43) | (1.18) | |
Revenue per Share |
8.90 | 8.23 | 7.83 | 7.23 | |
Operating CF per Share |
(1.39) | (1.43) | (1.47) | (1.79) | |
Capex per Share |
(0.42) | (0.38) | (0.39) | (0.32) | |
Capex to Sales |
0.05 | 0.05 | 0.05 | 0.04 | |
Net Profit Margin |
(38.33%) | (40.10%) | (42.39%) | (44.18%) |
Columns are period end dates